Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won
M Torreggiani, S Blanchi, A Fois, H Fessi… - Kidney …, 2021 - kidney-international.org
1. Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related
death using OpenSAFELY. Nature. 2020; 584: 430–436. 2. Glenn DA, Hegde A, Kotzen E, et
al. Systematic review of safety and efficacy of COVID-19 vaccines in patients with kidney
disease [e-pub ahead of print]. Kidney Int Rep. https://doi. org/10.1016/j. ekir. 2021.02. 011.
Accessed March 17, 2021. 3. Voysey M, Clemens SAC, Madhi SA, et al. Single-dose
administration and the influence of the timing of the booster dose on immunogenicity and …
death using OpenSAFELY. Nature. 2020; 584: 430–436. 2. Glenn DA, Hegde A, Kotzen E, et
al. Systematic review of safety and efficacy of COVID-19 vaccines in patients with kidney
disease [e-pub ahead of print]. Kidney Int Rep. https://doi. org/10.1016/j. ekir. 2021.02. 011.
Accessed March 17, 2021. 3. Voysey M, Clemens SAC, Madhi SA, et al. Single-dose
administration and the influence of the timing of the booster dose on immunogenicity and …
以上显示的是最相近的搜索结果。 查看全部搜索结果